CDT Equity (CDT) Accounts Payables (2023 - 2026)
CDT Equity's (CDT) quarterly Accounts Payables came in at $2.4 million in Q1 2026, up 238.38% YoY from $714000.0 in Q1 2025, and up 26.29% on a QoQ basis from $1.9 million in Q4 2025.
CDT Equity (CDT) Accounts Payables (2023 - 2026) Analysis & Trends
CDT Equity (CDT) has 4 years of Accounts Payables data on file, last reported at $2.4 million in Q1 2026.
- Quarterly Accounts Payables rose 238.38% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 238.38% YoY) and the FY2025 annual result came in at $1.9 million, up 33.96% from the prior year.
- Accounts Payables advanced to $2.4 million in Q1 2026, from $1.9 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $2.4 million in Q1 2026 to a low of $35000.0 in Q3 2023.
- A 4-year average of $952090.9 and a median of $714000.0 in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables surged 5314.29% — and 2025, when it slumped 94.08%.
- Tracing CDT's Accounts Payables over 4 years: stood at $215000.0 in 2023, then soared by 564.19% to $1.4 million in 2024, then jumped by 33.96% to $1.9 million in 2025, then climbed by 26.29% to $2.4 million in 2026.
- The last three Accounts Payables figures came in at $2.4 million (Q1 2026), $1.9 million (Q4 2025), and $613000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | 3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.73 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 613,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 714,000.00 |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 117,000.00 |
| Dec 31, 2023 | 215,000.00 |
| Sep 30, 2023 | 35,000.00 |